Lybeck, Julia
Tuomilehto, Jaakko
Saramies, Jouko
Koiranen, Markku
Uusitalo, Hannu
Keinänen-Kiukaanniemi, Sirkka
Suija, Kadri
Funding for this research was provided by:
University of Helsinki
Article History
Received: 11 January 2025
Accepted: 24 September 2025
First Online: 10 November 2025
Declarations
:
: The study was conducted according to the Declaration of Helsinki and was approved by the Ethics Review Board of the South Karelia Hospital District. The Research Ethics Committee of the University of Helsinki approved the research (HUS/2203/2018).Written informed consent was obtained from all participants prior to their inclusion in the study.
: Not applicable.
: J.T. owns stocks in Orion Pharma, Aktivolabs LTD and Digostics LTD. The other authors declare no potential conflict of interest relevant to this article.